Onsdag 28 Oktober | 19:03:47 Europe / Stockholm
Est. tid*
2027-11-23 07:10 Kvartalsrapport 2027-Q3
2027-08-25 07:10 Kvartalsrapport 2027-Q2
2027-05-26 07:10 Kvartalsrapport 2027-Q1
2027-03-16 N/A Årsstämma
2027-02-24 07:05 Bokslutskommuniké 2026
2026-11-26 07:10 Kvartalsrapport 2026-Q3
2026-08-25 - Kvartalsrapport 2026-Q2
2026-05-27 - Kvartalsrapport 2026-Q1
2026-03-26 - X-dag ordinarie utdelning FLUO 0.00 DKK
2026-03-25 - Årsstämma
2026-02-25 - Bokslutskommuniké 2025
2025-11-27 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-28 - Kvartalsrapport 2025-Q1
2025-03-28 - X-dag ordinarie utdelning FLUO 0.00 DKK
2025-03-27 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-11-27 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-30 - Kvartalsrapport 2024-Q1
2024-03-21 - X-dag ordinarie utdelning FLUO 0.00 DKK
2024-03-20 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-29 - Kvartalsrapport 2023-Q3
2023-08-30 - Kvartalsrapport 2023-Q2
2023-05-31 - Kvartalsrapport 2023-Q1
2023-03-22 - X-dag ordinarie utdelning FLUO 0.00 DKK
2023-03-21 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-31 - Kvartalsrapport 2022-Q1
2022-05-19 - X-dag ordinarie utdelning FLUO 0.00 DKK
2022-05-18 - Årsstämma
2022-03-30 - Bokslutskommuniké 2021
2021-11-24 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-05-26 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning FLUO 0.00 DKK
2021-02-26 - Bokslutskommuniké 2020
2021-02-09 - Årsstämma
2020-11-20 - Kvartalsrapport 2020-Q3
2020-08-14 - Kvartalsrapport 2020-Q2
2020-05-27 - Kvartalsrapport 2020-Q1
2020-04-09 - X-dag ordinarie utdelning FLUO 0.00 DKK
2020-04-08 - Årsstämma
2020-02-28 - Bokslutskommuniké 2019
2019-11-29 - Kvartalsrapport 2019-Q3
2019-05-31 - Kvartalsrapport 2019-Q1
LandDanmark
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
FluoGuide är ett danskt bolag verksamt inom medicinteknik. Bolaget affärsfokus återfinns inom forskning och utveckling av behandlingar av olika cancerformer, med störst fokus på utveckling av produkter som vägleder vid kirurgiska ingrepp. Produkterna binder till sig cancercellerna som då lyser upp och är avsedda att användas för att med precision kunna ta bort skadliga tumörer i patientens vävnad.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

FluoGuide issue warrants to employees, management, and Board of Directors

2021-05-28 09:04:27
Copenhagen, Denmark, 28 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that based on the approved Incentive program from 9 February 2021, FluoGuide is issuing 322,700 warrants to the Board of Directors, management, and employees.

Today, the Board of Directors of FluoGuide has exercised its authorization to issue new warrants by issuing 272,700 warrants to employees and management, and 50,000 warrants to the Board of Directors. All warrants are issued free of change.

Warrants are issued to ensure alignment of interests between the Company’s employees, management, Board of Directors, and shareholders. The Company believes that the issue of warrants will strengthen the achievement of FluoGuide’s short-term and long-term goals to support the Company’s business strategy, sustainability, and value creation for the benefit of shareholders.

The warrants are issued in accordance with FluoGuide’s authorization in Clause 3.1.4 and Clause 3.1.7 of the Articles of Association.

Each warrant grants the holder the right to subscribe for (1) one new share in FluoGuide. The exercise price is fixed at SEK 95,00 per share which corresponds to the subscription price in FluoGuide’s directed share issue that was conducted on 12 May 2021.

122,700 of the Warrants issued vest with 1/36 per month, and 200,000 warrants issued to certain members of the management shall vest with 1/60 per month subject to certain       KPI´s.

The theoretical market value of the allocation of the new warrants is up to SEK 50,32 per warrant. The calculation is based on the Black-Scholes formula using an interest rate of -0,07% and the historical volatility of FluoGuide shares calculated to 47,4%.

Todays issued warrants represents a total dilution of 2,85% of the current share capital, if vested and exercised. There are no other warrant programs.

Vested warrants may be exercised in two annual exercise periods of two weeks following publication of respectively the Annual Report and the Interim half-year report.

The detailed terms of all warrants issued by the Company can be found in the Articles of Association on the Company’s website under https://fluoguide.com/investor/compliance/, following registration with the Danish Business Authorities.